|
23-Mar-2021
Investor presentation, 23 March 2021
Investor presentation, 23 March 2021
|
12-Mar-2021
S&P DJI Announces March 2021 Quarterly Rebalance
S&P DJI Announces March 2021 Quarterly Rebalance
|
10-Mar-2021
Neuren successfully completes manufacturing for Phase 2
Neuren successfully completes manufacturing for Phase 2
|
24-Feb-2021
Neuren corporate presentation, 24 February 2021
Neuren corporate presentation, 24 February 2021
|
24-Feb-2021
Neuren approaching transforming milestones in 2021
Neuren approaching transforming milestones in 2021
|
24-Feb-2021
Preliminary Final Report and 2020 full year accounts
Preliminary Final Report and 2020 full year accounts
|
18-Feb-2021
Change of Director's Interest Notice
Change of Director's Interest Notice
|
17-Feb-2021
Notification of investor briefing webinar
Notification of investor briefing webinar
|
16-Feb-2021
Neuren adds Prader-Willi syndrome to NNZ-2591 pipeline
Neuren adds Prader-Willi syndrome to NNZ-2591 pipeline
|
15-Feb-2021
Successful Phase 1 trial for Neuren's NNZ-2591
Successful Phase 1 trial for Neuren's NNZ-2591
|